Subgroup | N | OR | LCI | UCI | POR | Model | Phetero | I2 | Pbegg | Pegger |
---|---|---|---|---|---|---|---|---|---|---|
Overall | 9 | 2.540 | 1.245 | 5.180 | 0.010 | R | 0.007 | 61.70% | 0.754 | 0.703 |
Control type | ||||||||||
Other temperature controls | 5 | 2.542 | 1.046 | 6.174 | 0.039 | R | 0.016 | 67.40% | ||
Non-TH induction | 4 | 2.364 | 0.564 | 9.919 | 0.240 | R | 0.046 | 62.50% | ||
Regions | ||||||||||
Japan | 3 | 3.478 | 0.625 | 19.373 | 0.155 | R | 0.002 | 83.60% | ||
Korea | 4 | 1.953 | 0.522 | 7.308 | 0.320 | R | 0.043 | 63.20% | ||
Sample size | ||||||||||
< 80 | 4 | 2.984 | 0.328 | 27.124 | 0.332 | R | 0.007 | 75.50% | ||
≥ 80 | 5 | 2.370 | 1.230 | 4.567 | 0.010 | R | 0.075 | 52.90% | ||
CA location | ||||||||||
Mixed | 4 | 1.703 | 1.004 | 2.889 | 0.048 | F | 0.193 | 36.50% | ||
OHCA | 5 | 3.759 | 1.001 | 14.122 | 0.050 | R | 0.015 | 67.60% | ||
mNOS score | ||||||||||
≥ 7 | 4 | 3.248 | 1.909 | 5.525 | < 0.001 | F | 0.112 | 49.90% | ||
< 7 | 5 | 1.540 | 0.461 | 5.141 | 0.482 | R | 0.019 | 66.10% | ||
OR obtained methods | ||||||||||
U | 8 | 2.683 | 1.134 | 6.347 | 0.025 | R | 0.004 | 66.10% | ||
M | 1 | |||||||||
Follow-up | ||||||||||
Discharge/30 days | 8 | 2.106 | 1.106 | 4.008 | 0.023 | R | 0.040 | 52.40% | ||
90 days | 1 |